Axogen Quarterly Balance Sheet
NASDAQ: AXGNHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Axogen financial position
As of Jun 30, 2026, Axogen reported total assets of $304.9 million, up 48.4% from a year earlier against total liabilities of $48.6 million. Shareholders' equity stood at $256.3 million, or 84.1% of assets. The company held $94.6 million in cash and equivalents against $0 of debt, a net cash position of $94.6 million.
The current ratio (current assets divided by current liabilities) was 6.60, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.00.
Summary generated from market data by MetaCap's automated system. Methodology
Axogen balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 94.57M | 82.65M | 35.55M | 23.90M | 20.04M | 18.10M | 27.55M | 18.66M | 19.19M | 15.71M | 31.02M | 31.09M |
| Short-Term Investments | 16.84M | 18.95M | 5.98M | 11.89M | 9.89M | 3.97M | 5.93M | 5.87M | 1.94M | 1.92M | 0 | 1.49M |
| Receivables | 34.13M | 28.31M | 26.17M | 30.77M | 28.03M | 26.30M | 24.11M | 24.63M | 25.15M | 24.21M | 25.15M | 23.26M |
| Inventory | 47.31M | 46.07M | 42.37M | 40.58M | 36.77M | 35.50M | 33.18M | 29.36M | 28.02M | 27.64M | 23.02M | 23.02M |
| Total Current Assets | 200.38M | 184.71M | 120.42M | 114.46M | 103.42M | 93.07M | 99.22M | 86.25M | 82.26M | 78.66M | 88.00M | 87.44M |
| Property, Plant & Equipment | 82.34M | 83.04M | 81.78M | 82.37M | 82.39M | 83.31M | 84.67M | 85.63M | 86.75M | 87.84M | 88.73M | 89.03M |
| Intangible Assets | 7.57M | 7.27M | 6.75M | 6.43M | 6.12M | 5.88M | 5.58M | 5.21M | 4.97M | 4.77M | 4.53M | 4.29M |
| Total Assets | 304.86M | 289.49M | 221.69M | 216.40M | 205.45M | 196.16M | 203.73M | 191.99M | 188.93M | 186.52M | 196.83M | 194.63M |
| Accounts Payable | 28.40M | 23.90M | 2.89M | 25.67M | 22.77M | 19.66M | 8.01M | 21.18M | 21.66M | 21.29M | 11.77M | 25.55M |
| Total Current Liabilities | 30.37M | 26.01M | 23.56M | 28.01M | 24.98M | 21.75M | 30.61M | 23.03M | 23.41M | 22.93M | 30.43M | 26.65M |
| Long-Term Debt | 0 | 0 | 48.39M | 48.16M | 47.94M | 47.72M | 47.50M | 47.27M | 47.05M | 46.83M | 46.60M | 46.38M |
| Total Liabilities | 48.61M | 44.68M | 92.84M | 95.59M | 93.18M | 90.80M | 99.82M | 92.58M | 93.25M | 93.36M | 101.16M | 96.82M |
| Shareholders' Equity | 256.26M | 244.81M | 128.85M | 120.81M | 112.28M | 105.36M | 103.91M | 99.41M | 95.69M | 93.16M | 95.67M | 97.81M |
| Retained Earnings | -328.06M | -326.55M | -306.96M | -293.81M | -294.51M | -295.09M | -291.26M | -291.71M | -289.85M | -287.93M | -281.30M | -277.40M |
| Total Debt | 0 | 0 | 48.39M | 48.16M | 47.94M | 47.72M | 47.50M | 47.27M | 47.05M | 46.83M | 46.60M | 46.38M |
| Net Cash (Debt) | 111.41M | 101.60M | -6.86M | -12.37M | -18.02M | -25.65M | -14.01M | -22.74M | -25.91M | -29.19M | -15.58M | -13.79M |
| Shares Outstanding | 53.66M | 53.15M | 47.20M | 46.12M | 45.77M | 45.51M | 44.15M | 44.00M | 43.82M | 43.69M | 43.12M | 43.04M |
This table shows 12 quarterly periods of Axogen's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow AXGN's reporting calendar. What is a balance sheet?